Driving factors and reduction paths dynamic simulation optimization of carbon dioxide emissions in China's construction industry under the perspective of dual carbon targets
Environmental Impact Assessment Review · 2025-03 · 112 · 107789
DOI: 10.1016/j.eiar.2024.107789 ↗Kurz gefasst
Fachartikel in der Zeitschrift Environmental Impact Assessment Review, 2025-03. Verfasst von Yujie Xian und 4 weiteren Autor:innen. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 95 Literaturangaben. Gefördert von: National Key Research and Development Program of China Stem Cell and Translational Research, National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Key Research and Development Program of China Stem Cell and Translational Research
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Xian, Y., Wang, H., Zhang, Z., Yang, Y., & Zhong, Y. (2025). Driving factors and reduction paths dynamic simulation optimization of carbon dioxide emissions in China's construction industry under the perspective of dual carbon targets. Environmental Impact Assessment Review, 112, 107789. https://doi.org/10.1016/j.eiar.2024.107789
Vancouver
Xian Y, Wang H, Zhang Z, Yang Y, Zhong Y. Driving factors and reduction paths dynamic simulation optimization of carbon dioxide emissions in China's construction industry under the perspective of dual carbon targets. Environmental Impact Assessment Review. 2025;112:107789. doi:10.1016/j.eiar.2024.107789
BibTeX
@article{Xian2025,
author = {Xian, Yujie and Wang, Huihui and Zhang, Zeyu and Yang, Yunsong and Zhong, Yuhao},
title = {Driving factors and reduction paths dynamic simulation optimization of carbon dioxide emissions in China's construction industry under the perspective of dual carbon targets},
journal = {Environmental Impact Assessment Review},
year = {2025},
volume = {112},
pages = {107789},
doi = {10.1016/j.eiar.2024.107789}
}
EUVIMED